GlassScriptPhysician profile
Anthony N Dardano
NPI 1992744007
$586,177.63
in general payments reported to CMS, 2019-2025
31 companies · $70K in 2025
The $70K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129K · 2020: $46K · 2021: $51K · 2022: $91K · 2023: $93K · 2024: $106K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $142K · Consulting Fee: $68K · Travel and Lodging: $30K · Food and Beverage: $8,022 · Grant: $6,375 · Education: $6,325 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,550 · Honoraria: $3,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $141,556.26 |
| Consulting Fee | $68,405.63 |
| Travel and Lodging | $29,691.07 |
| Food and Beverage | $8,021.91 |
| Grant | $6,375.00 |
| Education | $6,325.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,550.00 |
| Honoraria | $3,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $363,903.65 | 2019-2023 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
| Solventum Corporation | $90,805.27 | 2024-2025 | Prevena, V.A.C. Veraflo, Abthera |
| Aroa Biosurgery Incorporated | $75,529.42 | 2023-2025 | |
| Medical Device Business Services, INC. | $30,242.81 | 2020-2024 | Xcm Biologic Tissue Matrix, Matrixrib |
| Abbvie INC. | $6,923.92 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Baxter Healthcare | $6,189.88 | 2020-2021 | |
| Rti Surgical, INC | $3,600.00 | 2024-2025 | |
| Synthes Gmbh | $3,326.51 | 2022-2025 | |
| Depuy Synthes Sales INC. | $2,255.35 | 2019-2025 | Na, Matrixrib |
| Kerecis Limited | $609.80 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mentor Worldwide LLC | $370.77 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $276.22 | 2019-2025 | |
| Sanara Medtech INC. | $265.85 | 2021-2022 | |
| Sientra, INC. | $255.42 | 2019-2021 | |
| Polynovo North America LLC | $250.02 | 2019-2025 | Novosorb Btm |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up Sa | $193.50 | 2019 | |
| Silk Road Medical, INC. | $186.86 | 2022 | |
| Galderma Laboratories, L.P. | $173.61 | 2019-2023 | Dysport |
| Acera Surgical, INC. | $136.40 | 2023 | Restrata Wound Matrix |
| Acell, INC. | $130.29 | 2020 | |
| Medtronic, INC. | $112.28 | 2024 | Endo Gia Ultra |
| Davol INC. | $91.57 | 2022 | |
| Organogenesis INC. | $90.57 | 2021 | |
| Polarityte, INC. | $81.42 | 2019 | |
| Eagle Pharmaceuticals, INC. | $47.99 | 2019 | |
| Tela Bio, INC. | $43.97 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $26.00 | 2021 | |
| Synthes USA Products LLC | $16.13 | 2021 | |
| Merck Sharp & Dohme LLC | $15.42 | 2022 | |
| Morphosys, US INC. | $15.36 | 2021 | |
| Dova Pharmaceuticals | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Dardano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.